Clinical trial
Effect of Silymarin (Milk Thistle) on Hepatic Fibrosis, Glycemic Control and Biochemical Parameters in Type 2 Diabetic Patients
NCT07871370 is registered in ClinicalTrials.gov with University of Mosul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Silymarin (Milk Thistle) on Hepatic Fibrosis, Glycemic Control and Biochemical Parameters in Type 2 Diabetic Patients
- Lead sponsor
- University of Mosul
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 2, 2024
- Completion date
- June 1, 2026
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fatty liver, type 2 diabetes